Prognostic value of N-terminal pro-brain natriuretic peptide in outpatients with hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 112, Issue 8, 2013, Pages 1190-1196

  D'Amato, Rossella ^a   Tomberli, Benedetta ^b   Castelli, Gabriele ^b   Spoladore, Roberto ^a   Girolami, Francesca ^c   Fornaro, Alessandra ^b   Caldini, Anna ^b   Torricelli, Francesca ^c   Camici, Paolo ^a   Gensini, Gian Franco ^b   Cecchi, Franco ^b   Olivotto, Iacopo ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; ITALY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE;

EID: 84884907415     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.06.018     Document Type: Article

References (30)

1. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
2. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, and R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
3. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines American Association for Thoracic Surgery American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society Society for Cardiovascular Angiography and Interventions Society of Thoracic Surgeons 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 2761 2796
4. I. Olivotto, F. Cecchi, C. Poggesi, and M.H. Yacoub Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging Circ Heart Fail 5 2012 535 546
5. B.J. Maron Sudden death in hypertrophic cardiomyopathy J Cardiovasc Transl Res 2 2009 368 380
6. I. Olivotto, F. Girolami, S. Nistri, A. Rossi, L. Rega, F. Garbini, C. Grifoni, F. Cecchi, and M.H. Yacoub The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice J Cardiovasc Transl Res 2 2009 349 367
7. S.R. Ommen, B.J. Maron, I. Olivotto, M.S. Maron, F. Cecchi, S. Betocchi, B.J. Gersh, M.J. Ackerman, R.B. McCully, J.A. Dearani, H.V. Schaff, G.K. Danielson, A.J. Tajik, and R.A. Nishimura Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476
8. B.J. Maron Controversies in cardiovascular medicine: surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206
9. M.H. Yacoub, I. Olivotto, and F. Cecchi "End-stage" hypertrophic cardiomyopathy: from mystery to model Nat Clin Pract Cardiovasc Med 4 2007 232 233
10. P.O. Collinson, S.C. Barnes, D.C. Gaze, G. Galasko, A. Lahiri, and R. Senior Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers Eur J Heart Fail 6 2004 365 368
11. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2012 242 255
12. K.T. Yeo, A.H. Wu, F.S. Apple, M.H. Kroll, R.H. Christenson, K.B. Lewandrowski, F.A. Sedor, and A.W. Butch Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay Clin Chim Acta 338 2003 107 115
13. S.F. Nagueh, S.M. Bierig, M.J. Budoff, M. Desai, V. Dilsizian, B. Eidem, S.A. Goldstein, J. Hung, M.S. Maron, S.R. Ommen, and A. Woo American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography J Am Soc Echocardiogr 24 2011 473 498
14. B. Pinamonti, A. Di Lenarda, G. Nucifora, D. Gregori, A. Perkan, and G. Sinagra Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study Eur J Echocardiogr 9 2008 466 471
15. I. Olivotto, F. Girolami, M.J. Ackerman, S. Nistri, J.M. Bos, E. Zachara, S.R. Ommen, J.L. Theis, R.A. Vaubel, F. Re, C. Armentano, C. Poggesi, F. Torricelli, and F. Cecchi Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy Mayo Clin Proc 83 2008 630 638
16. B.J. Maron, I. Olivotto, P. Spirito, S.A. Casey, P. Bellone, T.E. Gohman, K.J. Graham, D.A. Burton, and F. Cecchi Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
17. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
18. B.J. Maron, V.N. Tholakanahalli, A.G. Zenovich, S.A. Casey, D. Duprez, D.M. Aeppli, and J.N. Cohn Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 2004 984 989
19. J.R. Park, J.O. Choi, H.J. Han, S.A. Chang, S.J. Park, S.C. Lee, Y.H. Choe, S.W. Park, and J.K. Oh Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging Int J Cardiovasc Imaging 28 2012 763 772
20. M. Vanderheyden, M. Goethals, S. Verstreken, B. De Bruyne, K. Muller, E. Van Schuerbeeck, and J.J. Bartunek Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy Am Coll Cardiol 44 2004 2349 2354
21. B. Mutlu, F. Bayrak, G. Kahveci, M. Degertekin, E. Eroglu, and Y. Basaran Usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy Am J Cardiol 98 2006 1504 1506
22. H. Kitaoka, T. Kubo, M. Okawa, N. Takenaka, C. Sakamoto, Y. Baba, K. Hayashi, N. Yamasaki, Y. Matsumura, and Y.L. Doi Tissue Doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy J Am Soc Echocardiogr 24 2011 1020 1025
23. C.J. Coats, M.J. Gallagher, M. Foley, C. O'Mahony, C. Critoph, J. Gimeno, A. Dawnay, W.J. McKenna, and P.M. Elliott Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy Eur Heart J 2013 Mar 8
24. M.S. Maron, I. Olivotto, S. Betocchi, S.A. Casey, J.R. Lesser, M.A. Losi, F. Cecchi, and B.J. Maron Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Eng J Med 348 2003 295 303
25. P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, E. Donal, J.F. Aupetit, M.C. Aumont, M. Galinier, J.C. Eicher, A. Cohen-Solal, and Y. Juillière Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739
26. K. Hasegawa, H. Fujiwara, K. Doyama, M. Miyamae, T. Fujiwara, S. Suga, M. Mukoyama, K. Nakao, H. Imura, and S. Sasayama Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy Circulation 88 1993 372 380
27. T. Tsuruda, G. Boerrigter, B.K. Huntley, J.A. Noser, A. Cataliotti, L.C. Costello-Boerrigter, H.H. Chen, and J.C. Burnett Jr. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases Circ Res 91 2002 1127 1134
28. R. Lombardi, S. Betocchi, M.A. Losi, C.G. Tocchetti, M. Aversa, M. Miranda, G. D'Alessandro, A. Cacace, Q. Ciampi, and M. Chiariello Myocardial collagen turnover in hypertrophic cardiomyopathy Circulation 108 2003 1455 1460
29. I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P.G. Camici Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
30. T. Nakamura, K. Sakamoto, T. Yamano, M. Kikkawa, K. Zen, T. Hikosaka, T. Kubota, A. Azuma, and T. Nishimura Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 1657 1663